Dow futures rose 0.7%, S&P 500 futures rose nearly 1%, and Nasdaq futures rose 1.2%. In the Asian market, the Nikkei 225 index opened lower by 1.4%, and the South Korean KOSPI index opened lower by 1.6%.
The new crown epidemic is currently one of the biggest risks facing the stock market. However, it is difficult to say the influence and sustainability of the latest Omicron variant virus on the market. At least the current overall market situation shows that panic sentiment tends to ease.
U.S. stock futures began to rebound after Friday’s sharp decline. Dow futures rose 0.7%, S&P 500 futures rose nearly 1%, and Nasdaq futures rose 1.2%.
Oil prices rebounded, with U.S. oil rising more than 5%, and Bursa oil, which is the basis of international oil prices, rising more than 4%.
The safe-haven asset gold once plunged $10 in the intraday trading and erased the decline.
U.S. Treasury prices fell across the board. The 2-year U.S. Treasury yield rose 4 basis points to 0.54%, and the 5-year and 10-year U.S. Treasury yields both rose 3 basis points, hitting 1.22% and 1.53%, respectively.
Asian market slumps in early trading
In the Asian market, the Nikkei 225 index opened lower by 1.4%, and the Topix index opened lower by 1.5%, and then the decline narrowed.
South Korea’s KOSPI index fell 1.6% at the opening, and then the decline narrowed. Australia’s S&P/ASX200 index fell to 7,238 points.
In addition, Indonesia’s main stock index fell 1%, Vietnam’s VN index fell nearly 2%, and then the decline narrowed, and the New Zealand stock index also fell.
Omicron panic relief?
According to previous articles on Wall Street, although many people believe that the Omicron variant virus is more aggressive and deadly than Delta or any other new coronavirus variants, Goldman Sachs believes that there is still not enough information to make a comprehensive prediction of Omicron.
On Friday night, Goldman Sachs stated in a report that the reality may not be so bad:
Investors can hedge short-term risk assets, but there is no reason to change the investment portfolio.
In addition, on November 25, the South African National Institute of Infectious Diseases (NICD) issued a statement stating that Omicron is unlikely to be worse, and that existing vaccines will continue to provide a high level of protection to effectively prevent hospitalization and death. Current PCR virus testing and antigen testing are expected to continue to identify mutations.
The NICD specifically pointed out that at present, the infected person has not reported abnormal symptoms after being infected with Omi Keron. Angelique Coetzee, President of the South African Medical Association, said yesterday:
The Omi Keron variant currently causes only mild illness without any obvious symptoms.
Risk warning and exemption clause
Market risk, the investment need to be cautious. This article does not constitute personal investment advice, nor does it take into account the specific investment objectives, financial situation or needs of individual users. Users should consider whether any opinions, opinions, or conclusions in this article are consistent with their specific conditions. Invest accordingly at your own risk.